Literature DB >> 22610610

Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.

Alexander T Cartus1, Kristin Herrmann, Lucas W Weishaupt, Karl-Heinz Merz, Wolfram Engst, Hansruedi Glatt, Dieter Schrenk.   

Abstract

Methyleugenol (1) is a constituent of many foods, in particular of herbal spices, and is used as flavoring agent in foodstuffs and as fragrance in cosmetics. 1 has been found to be carcinogenic in rodents, its metabolite, 1-hydroxymethyleugenol (2) acting as proximate DNA-binding carcinogen. We incubated 1 with liver microsomes of rat, bovine, and human origin. We found 2, 3-hydroxymethylisoeugenol (3), and 6-hydroxymethyleugenol (4) as major metabolites, and 1-oxomethyleugenol (5), 3-oxomethylisoeugenol (6), eugenol (9), chavibetol (11), and (RS)-2,3-dihydroxy-2,3-dihydromethyleugenol (7) as minor metabolites. Methyleugenol-2,3-epoxide (8), probably the precursor of 7, could not be detected. Incubations with synthetic metabolites were applied in order to uncover metabolic pathways. Incubations with primary rat hepatocytes revealed mainly nonconjugated 2 and conjugated 4, and minor amounts of partly conjugated 7 and conjugated 9 + 11. The "reactive metabolites" 3, 5, 6, and 8 were not detectable, possibly due to rapid reaction with cellular macromolecules. The highest cytotoxicity (resazurin reduction assay and lactate dehydrogenase leakage assay) was observed for the main metabolite 2 and its secondary metabolite 5 with EC(50) values of 50 and 10 µM, respectively. Deoxyadenosine or deoxyguanosine adducts were formed by incubating 1 or metabolites with rat hepatocytes. The rank order of adduct formation was 2 > 1 > 3 > 6, whereas 4, 5, and 8 were inactive. In conclusion, we present a virtually complete pattern of microsomal (rat, bovine, and human) and hepatocellular (rat) metabolites of 1 suggesting the formation of several reactive metabolites possibly involved in carcinogenicity, organ toxicity, and immune reactions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610610     DOI: 10.1093/toxsci/kfs181

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  6 in total

1.  The influence of the SULT1A status - wild-type, knockout or humanized - on the DNA adduct formation by methyleugenol in extrahepatic tissues of mice.

Authors:  K Herrmann; W Engst; S Florian; A Lampen; W Meinl; H R Glatt
Journal:  Toxicol Res (Camb)       Date:  2016-02-12       Impact factor: 3.524

2.  Free radical metabolism of methyleugenol and related compounds.

Authors:  Herbert J Sipe; Olivier M Lardinois; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2014-03-07       Impact factor: 3.739

3.  Modified Ames test using a strain expressing human sulfotransferase 1C2 to assess the mutagenicity of methyleugenol.

Authors:  Hiroshi Honda; Kazuyuki Minegawa; Yurika Fujita; Noriko Yamaguchi; Yoshihiro Oguma; Hansruedi Glatt; Naohiro Nishiyama; Toshio Kasamatsu
Journal:  Genes Environ       Date:  2016-02-07

4.  Plant polyphenols and oxidative metabolites of the herbal alkenylbenzene methyleugenol suppress histone deacetylase activity in human colon carcinoma cells.

Authors:  Isabel Anna Maria Groh; Chen Chen; Claudia Lüske; Alexander Thomas Cartus; Melanie Esselen
Journal:  J Nutr Metab       Date:  2013-02-11

5.  Cellular levels and molecular dynamics simulations of estragole DNA adducts point at inefficient repair resulting from limited distortion of the double-stranded DNA helix.

Authors:  Shuo Yang; Matthias Diem; Jakob D H Liu; Sebastiaan Wesseling; Jacques Vervoort; Chris Oostenbrink; Ivonne M C M Rietjens
Journal:  Arch Toxicol       Date:  2020-03-18       Impact factor: 5.153

6.  The Relative Content and Distribution of Absorbed Volatile Organic Compounds in Rats Administered Asari Radix et Rhizoma Are Different between Powder- and Decoction-Treated Groups.

Authors:  Guang-Xue Liu; Feng Xu; Ming-Ying Shang; Xuan Wang; Shao-Qing Cai
Journal:  Molecules       Date:  2020-09-27       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.